×
精神障碍诊断与统计手册(第五版-修订版)(DSM-5-TR)

精神障碍诊断与统计手册(第五版-修订版)(DSM-5-TR)

1星价 ¥304.3 (8.5折)
2星价¥304.3 定价¥358.0
暂无评论
图文详情
  • ISBN:9787301348598
  • 装帧:一般胶版纸
  • 册数:暂无
  • 重量:暂无
  • 开本:16开
  • 页数:1169
  • 出版时间:2024-04-01
  • 条形码:9787301348598 ; 978-7-301-34859-8

本书特色

《精神障碍诊断与统计手册》(DSM)被誉为精神医学领域的"圣经",2022年3月美国精神医学学会(APA)在DSM-5的基础上推出了DSM-5-TR。该版本对绝大多数障碍的文本进行了修订;增加了“延长哀伤障碍”的诊断;将*初发布的 DSM-5 诊断标准与对 70 多种障碍的修改(大部分做了澄清)相整合;全面更新了“介绍”和“使用手册”部分,并为重要术语提供上下文背景,以指导临床工作者使用;采用了更新的ICD-10-CM编码,并新增了50多个有关物质中毒、物质戒断和其他障碍的编码。 DSM-5-TR是精神卫生临床工作者和研究人员不可或缺的临床实践资源,对于精神障碍的诊断具有重要的指导意义。期盼DSM-5-TR中文版的问世,为国内广大相关专业人员提供极具价值的参考和借鉴。

内容简介

美国精神医学学会于2013年5月推出了美国精神障碍分类与诊断标准的近期新版本——《精神障碍诊断与统计手册(第五版)》(DSM-5)。DSM被誉为精神障碍领域的"圣经",是一本美国及其他国家常用的诊断精神障碍的指导手册。为了能进一步改进精神疾病的诊断、治疗、科研和在所有临床工作者中产生一种共同语言,DSM-5对所有精神疾病进行了重新定义和分类,并制订了准确和具体的诊断标准,因而极具实用价值。 本书(DSM-5-TR)是DSM-5的文本修订版。该版本对DSM-5的绝大多数障碍的文本进行了修订,更新了相关特征、患病率、发展与病程、风险与预后因素、与文化相关的诊断问题、诊断标志物、与自杀想法或行为的相关性、鉴别诊断等内容;增加了“延长哀伤障碍”的诊断;将*初发布的 DSM-5 诊断标准与对 70 多种障碍的修改(大部分做了澄清)相整合;全面更新了“介绍”和“使用手册”部分,并为重要术语提供上下文背景,以指导临床工作者使用;采用了更新的ICD-10-CM编码,并新增了50多个有关物质中毒、物质戒断和其他障碍的编码。 DSM-5-TR是精神卫生临床工作者和研究人员不可或缺的临床实践资源,对于精神障碍的诊断具有重要的指导意义。期盼DSM-5-TR中文版的问世,为国内广大相关专业人员提供极具价值的参考和借鉴。

目录

目 录 **部分 DSM-5 基础 介绍································································································································5 使用手册 ·······················································································································21 DSM-5 司法谨慎使用声明 ···························································································29 第二部分 诊断标准与编码 神经发育障碍 ···············································································································35 精神分裂症谱系及其他精神病性障碍 ··········································································97 双相及相关障碍 ·········································································································135 抑郁障碍 ····················································································································· 171 焦虑障碍 ····················································································································· 209 强迫及相关障碍 ········································································································ 257 创伤及应激相关障碍 ··································································································289 分离障碍 ····················································································································· 323 躯体症状及相关障碍 ··································································································343 喂食及进食障碍 ·········································································································365 排泄障碍 ····················································································································· 391 睡眠-?觉醒障碍 ··········································································································399 性功能失调 ················································································································· 469 性别烦躁 ····················································································································· 501 破坏性、冲动控制及品行障碍 ··················································································· 511 精神障碍诊断与统计手册(第五版-修订版)(DSM-5-TR) 物质相关及成瘾障碍 ··································································································533 神经认知障碍 ············································································································· 657 人格障碍 ····················································································································· 721 性欲倒错障碍 ············································································································· 765 其他精神障碍和额外编码 ··························································································789 药物所致的运动障碍及其他药物不良反应 ································································793 可能成为临床关注焦点的其他状况 ···········································································807 第三部分 新出现的量表和模式 评估量表 ····················································································································· 827 文化与精神障碍诊断 ··································································································841 人格障碍的 DSM-5 替代模式 ····················································································859 需要进一步研究的状况 ······························································································877 附录 DSM-5-TR 诊断和 ICD-10-CM 编码的英文字母排序 ··············································899 DSM-5-TR 诊断和 ICD-10-CM 编码的数字排序 ······················································943 索引 ·························································································································· 1001
展开全部

作者简介

美国精神医学学会(American Psychiatric Association, APA),美国精神科医生的专业组织,在行业内具有全球性的影响力。现有约38000名会员,大部分在美国。其出版物除学术期刊及小册子以外,*为人熟悉的就是《精神障碍诊断与统计手册》,简称“DSM”。这本手册是美国主要诊断精神障碍的重要标准,也是全世界许多国家在诊断精神障碍上的重要参考。 【美国】张道龙 ---------------------------- 张道龙,毕业于哈尔滨医科大学并完成神经病学住院医师培训,中国大陆首位毕业于美国芝加哥大学精神医学系的精神科医生,河北医科大学、齐齐哈尔医学院等国内医学院客座教授。现就职于美国帕洛阿托退伍军人医学中心(斯坦福大学教学医院),珠海市第三人民医院国际精神心理服务部首席专家。深耕精神心理30余年,亲自诊治中美来访者及患者超过20万人次,曾获得美国精神医学学会促进少数族裔精神健康奖;北美华人医师联盟 2017年度、2018年、2022年“医学教育奖”,**位将美式 EAP 员工帮助计划、SAP学生帮助计划引进中国的专家,历时10余年翻译、编写完成12本教材

预估到手价 ×

预估到手价是按参与促销活动、以最优惠的购买方案计算出的价格(不含优惠券部分),仅供参考,未必等同于实际到手价。

确定
快速
导航